![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants
Tomokazu Tamura, Jumpei Ito, Keiya Uriu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 249
Tomokazu Tamura, Jumpei Ito, Keiya Uriu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 249
Showing 1-25 of 249 citing articles:
ACE2 binding and antibody evasion in enhanced transmissibility of XBB.1.5
Can Yue, Weiliang Song, Lei Wang, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 3, pp. 278-280
Open Access | Times Cited: 272
Can Yue, Weiliang Song, Lei Wang, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 3, pp. 278-280
Open Access | Times Cited: 272
Virological characteristics of the SARS-CoV-2 omicron XBB.1.16 variant
Daichi Yamasoba, Keiya Uriu, Arnon Plianchaisuk, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 6, pp. 655-656
Open Access | Times Cited: 128
Daichi Yamasoba, Keiya Uriu, Arnon Plianchaisuk, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 6, pp. 655-656
Open Access | Times Cited: 128
Enhanced transmissibility, infectivity, and immune resistance of the SARS-CoV-2 omicron XBB.1.5 variant
Keiya Uriu, Jumpei Ito, Jiří Zahradník, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 3, pp. 280-281
Open Access | Times Cited: 119
Keiya Uriu, Jumpei Ito, Jiří Zahradník, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 3, pp. 280-281
Open Access | Times Cited: 119
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
Jumpei Ito, Rigel Suzuki, Keiya Uriu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 113
Jumpei Ito, Rigel Suzuki, Keiya Uriu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 113
The rapid rise of SARS‐CoV‐2 Omicron subvariants with immune evasion properties: XBB.1.5 and BQ.1.1 subvariants
Danyi Ao, Xuemei He, Weiqi Hong, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 100
Danyi Ao, Xuemei He, Weiqi Hong, et al.
MedComm (2023) Vol. 4, Iss. 2
Open Access | Times Cited: 100
Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants EG.5.1 and XBB.2.3
Julia N. Faraone, Panke Qu, Negin Goodarzi, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 63
Julia N. Faraone, Panke Qu, Negin Goodarzi, et al.
Emerging Microbes & Infections (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 63
Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455–456 synergistically enhances antibody evasion and ACE2 binding
Fanchong Jian, Leilei Feng, Sijie Yang, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 12, pp. e1011868-e1011868
Open Access | Times Cited: 63
Fanchong Jian, Leilei Feng, Sijie Yang, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 12, pp. e1011868-e1011868
Open Access | Times Cited: 63
Virological characteristics of the SARS-CoV-2 BA.2.86 variant
Tomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 170-180.e12
Open Access | Times Cited: 51
Tomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
Cell Host & Microbe (2024) Vol. 32, Iss. 2, pp. 170-180.e12
Open Access | Times Cited: 51
Antiviral efficacy of the SARS-CoV-2 XBB breakthrough infection sera against omicron subvariants including EG.5
Yu Kaku, Yusuke Kosugi, Keiya Uriu, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 10, pp. e395-e396
Open Access | Times Cited: 49
Yu Kaku, Yusuke Kosugi, Keiya Uriu, et al.
The Lancet Infectious Diseases (2023) Vol. 23, Iss. 10, pp. e395-e396
Open Access | Times Cited: 49
Evolution of antibody immunity following Omicron BA.1 breakthrough infection
Chengzi I. Kaku, Tyler N. Starr, Pan-Pan Zhou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Chengzi I. Kaku, Tyler N. Starr, Pan-Pan Zhou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants
Nita Patel, Jessica F. Trost, Mimi Guebre‐Xabier, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 42
Nita Patel, Jessica F. Trost, Mimi Guebre‐Xabier, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 42
Impact of National Omicron Outbreak at the end of 2022 on the future outlook of COVID-19 in China
Liwei Zheng, Shuying Liu, Fengmin Lu
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 41
Liwei Zheng, Shuying Liu, Fengmin Lu
Emerging Microbes & Infections (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 41
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant
Tomokazu Tamura, Takashi Irie, Sayaka Deguchi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 39
Tomokazu Tamura, Takashi Irie, Sayaka Deguchi, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 39
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
Ann‐Kathrin Reuschl, Lucy Thorne, Matthew Whelan, et al.
Nature Microbiology (2024) Vol. 9, Iss. 2, pp. 451-463
Open Access | Times Cited: 38
Ann‐Kathrin Reuschl, Lucy Thorne, Matthew Whelan, et al.
Nature Microbiology (2024) Vol. 9, Iss. 2, pp. 451-463
Open Access | Times Cited: 38
The Emergence and Evolution of SARS-CoV-2
Edward C. Holmes
Annual Review of Virology (2024) Vol. 11, Iss. 1, pp. 21-42
Closed Access | Times Cited: 18
Edward C. Holmes
Annual Review of Virology (2024) Vol. 11, Iss. 1, pp. 21-42
Closed Access | Times Cited: 18
Key mechanistic features of the trade-off between antibody escape and host cell binding in the SARS-CoV-2 Omicron variant spike proteins
Weiwei Li, Zepeng Xu, Tianhui Niu, et al.
The EMBO Journal (2024) Vol. 43, Iss. 8, pp. 1484-1498
Open Access | Times Cited: 15
Weiwei Li, Zepeng Xu, Tianhui Niu, et al.
The EMBO Journal (2024) Vol. 43, Iss. 8, pp. 1484-1498
Open Access | Times Cited: 15
Evolution of the SARS-CoV-2 Omicron Variants: Genetic Impact on Viral Fitness
Wenhao Liu, Zehong Huang, Jin Xiao, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 184-184
Open Access | Times Cited: 14
Wenhao Liu, Zehong Huang, Jin Xiao, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 184-184
Open Access | Times Cited: 14
Systematic detection of co-infection and intra-host recombination in more than 2 million global SARS-CoV-2 samples
Orsolya Pipek, Anna Medgyes‐Horváth, József Stéger, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Orsolya Pipek, Anna Medgyes‐Horváth, József Stéger, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Mutations in the SARS-CoV-2 spike receptor binding domain and their delicate balance between ACE2 affinity and antibody evasion
Song Xue, Yuru Han, Fan Wu, et al.
Protein & Cell (2024) Vol. 15, Iss. 6, pp. 403-418
Open Access | Times Cited: 12
Song Xue, Yuru Han, Fan Wu, et al.
Protein & Cell (2024) Vol. 15, Iss. 6, pp. 403-418
Open Access | Times Cited: 12
The immune response to SARS-CoV-2 in people with HIV
Maxine A. Höft, Wendy A. Burgers, Catherine Riou
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 184-196
Open Access | Times Cited: 28
Maxine A. Höft, Wendy A. Burgers, Catherine Riou
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 184-196
Open Access | Times Cited: 28
Virological characteristics of the SARS-CoV-2 BA.2.86 variant
Tomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 28
Tomokazu Tamura, Keita Mizuma, Hesham Nasser, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 28
SARS-CoV-2 Omicron entry is type II transmembrane serine protease-mediated in human airway and intestinal organoid models
Anna Z. Mykytyn, Tim I. Breugem, Maarten H. Geurts, et al.
Journal of Virology (2023) Vol. 97, Iss. 8
Open Access | Times Cited: 27
Anna Z. Mykytyn, Tim I. Breugem, Maarten H. Geurts, et al.
Journal of Virology (2023) Vol. 97, Iss. 8
Open Access | Times Cited: 27
Evolution of the SARS-CoV-2 Omicron spike
Ruth Parsons, Priyamvada Acharya
Cell Reports (2023) Vol. 42, Iss. 12, pp. 113444-113444
Open Access | Times Cited: 26
Ruth Parsons, Priyamvada Acharya
Cell Reports (2023) Vol. 42, Iss. 12, pp. 113444-113444
Open Access | Times Cited: 26
COVID-19 annual update: a narrative review
Michela Biancolella, Vito Luigi Colona, Lucio Luzzatto, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 25
Michela Biancolella, Vito Luigi Colona, Lucio Luzzatto, et al.
Human Genomics (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 25
Markov State Models and Perturbation-Based Approaches Reveal Distinct Dynamic Signatures and Hidden Allosteric Pockets in the Emerging SARS-Cov-2 Spike Omicron Variant Complexes with the Host Receptor: The Interplay of Dynamics and Convergent Evolution Modulates Allostery and Functional Mechanisms
Sian Xiao, Mohammed Alshahrani, Grace Gupta, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 16, pp. 5272-5296
Open Access | Times Cited: 25
Sian Xiao, Mohammed Alshahrani, Grace Gupta, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 16, pp. 5272-5296
Open Access | Times Cited: 25